T
here are many theoretical advantages to providing nutritional support to critically ill patients, such as improved respiratory muscle strength, ventilatory response to hypoxemia and hypercapnia, cardiac function, and wound healing (1) (2) (3) (4) (5) (6) (7) . These potential benefits have led a number of organizations to publish consensus statements, based on expert opinion and limited data from surgical, burn, and trauma patients, promoting aggressive nutritional supplementation (8 -11) .
The paucity of data from rigorous studies evaluating the benefits and risks of nutritional supplementation in critically ill medical patients, however, continues to promote controversy regarding the importance of feeding during the relatively limited duration of an intensive care unit (ICU) stay (11, 12) . The effect of caloric intake on infection has been a central issue in the debate about whether to feed critically ill patients. Malnutrition has been associated with poor immune function, which increases the risk of systemic infection (13) . On the other hand, continuous enteric feeding has been associated with an increased risk of ventilator-associated pneumonia, presumably due to an increased risk of aspiration (14) . Moreover, total parenteral nutrition (TPN) compared with enteral feeding has been associated with greater risk of infection (15) (16) (17) . However, the overall impact of feeding on the risk of infection for critically ill medical patients remains uncertain (18) .
Nosocomial bloodstream infections (BSIs) are a major source of morbidity and mortality for hospitalized patients and disproportionately affect patients in ICUs (19 -22) . The increasing number of ICU beds in the United States (23) , coupled with the increasing prevalence of antimicrobial-resistant nosocomial pathogens (24) , has made prevention of nosocomial BSIs a national healthcare priority (10) . The objective of this investigation was to evaluate the relationship between caloric intake and the development of nosocomial BSI in medical ICU patients.
METHODS
Study Design. This was a prospective cohort study of nutritional support for critically ill medical patients. All patients admitted to the medical ICU (MICU) at Johns Hopkins Hospital between February 1999 and October 2000 were screened for eligibility. Patients were eligible if they did not take any food by mouth for Ն96 hrs after MICU admission. We restricted inclusion to this group since we intended to assess caloric intake relative to the American College of Chest Physicians (ACCP) guidelines, which were written specifically for adult ICU patients expected to be without oral intake for Ն4 days (11) . Patients were ineligible if they a) had a MICU length of stay Յ96 hrs; b) had a do-not-resuscitate order written Յ96 hrs after MICU admission; c) were transferred from another intensive care unit; d) had a previous MICU visit during the same hospitalization; e) had participated previously in the study; or f) were admitted for postoperative monitoring. Decisions regarding nutritional supplementation were made by the physician team providing care to MICU patients, in consultation with registered dietitians. Immunomodulatory formulas and specific protocolized feeding (e.g., to standardize timing of initiation of feeding, selection of nutrition formulas, decisions about gastric vs. postpyloric feeding, and use of prokinetic agents) were not used during the study period. Protocols for central venous catheter insertion or maintenance were not used during the study. Also, antimicrobial-impregnated catheters and a protocol to maintain serum glucose within predefined targets were not employed during the study period. This study met the criteria for waiver of informed consent, which was approved by the Johns Hopkins Hospital Institutional Review Board.
Comorbidities that may influence risk of infection (diabetes mellitus, chronic renal insufficiency, cirrhosis, and severe chronic obstructive pulmonary disease) were recorded at MICU admission. Simplified Acute Physiology Score (SAPS) II variables (25) , which included history of acquired immunodeficiency syndrome, gender, height, weight, serum albumin, number of hospital days before MICU admission, source of admission, and reason for admission (respiratory failure, circulatory failure, cardiac arrest, encephalopathy, and other), also were recorded for eligible patients at the time of MICU admission. Daily caloric intake was recorded (route of administration, formula type, and volume of formula) starting on the day of MICU admission and collected until a) the patient died in the MICU; b) the patient was transferred out of the MICU; c) a do-not-resuscitate order was written for the patient; or d) the patient took food by mouth. In addition, results of serum glucose measurements obtained by the clinical team managing the patient were recorded. Use of mechanical ventilation during the MICU stay was noted.
Baseline height and weight were used to calculate body mass index (BMI), and ideal body weight was calculated consistent with the ACCP guidelines recommendations (11) . The ACCP recommends that caloric intake for each ICU day be based on the patient's ideal body weight (25 kcal/kg or 27.5 kcal/kg in the presence of systemic inflammatory response syndrome). The daily caloric intake received was divided by the recommended calories to calculate the daily percent of recommended caloric intake received. To quantify glycemia, average daily serum glucose concentrations were calculated, and the maximum measured daily glucose concentrations were noted. Then the mean average daily serum glucose concentrations and the mean maximum daily glucose concentrations during their MICU stay were determined for each patient.
Outcome. The primary outcome of this study was the development of a nosocomial BSI in the MICU, since the diagnosis of BSI was based on objective criteria and therefore was unlikely to be affected by investigator bias (unlike other nosocomial infections such as ventilator-associated pneumonia). Blood cultures were collected when a BSI was suspected by the clinical team, who were unaware that BSI was to be an outcome of the study. The Johns Hopkins Epidemiology and Infection Control team identified the nosocomial BSIs as part of an ongoing institutional quality improvement effort, and they were unaware of the present study's hypothesis. The definition of nosocomial BSI in the MICU was based on the Centers for Disease Control and Prevention's criterion: a confirmed BSI that had occurred Ն48 hrs after MICU admission and within 48 hrs of MICU discharge (26) . Nosocomial BSIs were categorized as primary (defined as bacteremia or fungemia not related to infection at another site) or secondary (26) . Intravascular catheter-related BSIs were recorded as primary BSIs, and the causative site of BSI was noted for secondary BSIs. Only the patients' first nosocomial BSIs were included in this investigation.
Statistical Analysis. Analyses were performed using STATA (version 6.0, College Station, TX) (27) . Patients were categorized into quartiles of caloric intake based on the average daily percent of ACCP-recommended calories (Ͻ25%, 25-49%, 50 -74%, and Ն75%). The categories were created post hoc and selected to approximately balance the numbers of patients in each nutrition group. Since the nutrition provided on a given day might influence future but not immediate risk of infection, we included a 2-day lag period between caloric intake and BSI in the analyses. For instance, if a patient developed a BSI on MICU day 6, only the calories received during the first 4 MICU days would be used in the analysis. A sensitivity analysis for lagging nutrition 1-4 days before censoring was performed to evaluate this 2-day lag period assumption. The same lag period also was used to investigate the association between average serum glucose concentrations and BSI. A nonparametric test of trend was first used to assess the relationship of all potential confounders (comorbidities, reason for MICU admission, SAPS II scores, age, gender, MICU admission source, number of hospital days before MICU admission, being mechanically ventilated, serum albumin and BMI at MICU admission, days before initiating nutritional support, and route of nutrition) with caloric intake. If the test of trend was nonsignificant, Kruskal-Wallis tests (for continuous variables) or Fisher's exact tests and chi-square tests (for categorical variables) were employed (27) (28) . The appropriate measures of parenteral nutrition (TPN or peripheral parenteral nutrition) to assess impact on BSI risk have not been well characterized, so we used a variety of measures in the analysis including a) the percent of total calories received that were provided by the parenteral route; b) the number of MICU days receiving parenteral nutrition; and c) the percent of total MICU study days during which the patient received parenteral nutrition.
Since subjects were eligible for participation 96 hrs following MICU admission, only patients who were free from a nosocomial BSI during the first 96 hrs in the MICU were included in this analysis. Survival analyses, incorporating late entry (i.e., 96 hrs after MICU admission) were employed for bivariate and multivariable analyses. Kaplan-Meier curves and Cox proportional hazards methods were used (29) . Differences in Kaplan-Meier functions were assessed by log rank tests. SAPS II score, serum albumin and BMI at MICU admission, prior hospital days before MICU admission, average daily serum glucose and average maximum daily serum glucose, number of MICU days before starting nutritional support, and measures of total parenteral nutrition were assessed in bivariate Cox models. Only the comorbidities and reasons for admission that were statistically significantly different (p Ͻ .05) among categories of caloric intake were evaluated in bivariate Cox models. Age and presence of acquired immunodeficiency syndrome were not included as independent covariates since they are components of the SAPS II score. Mechanical ventilation also was not included since nearly all study participants were prescribed ventilatory support. A multivariable Cox model was established using the predictors that significantly predicted BSI risk in the bivariate Cox analyses. A two-tailed p value Ͻ.05 indicated statistical significance for all analyses.
RESULTS
During the study period, 1,195 patients were admitted to the MICU at Johns Hopkins Hospital. Of these patients, 138 (11.5%) met eligibility criteria and were included in the analyses. The remaining 1,057 (88.5%) patients were excluded for the following reasons: a) MICU length of stay Ͻ96 hrs, 762 (72.1%); b) transferred from other Johns Hopkins Hospital ICUs, 122 (11.5%); c) transferred from other facilities, 71 (6.7%); d) ate food by mouth within 96 hrs of MICU admission, 60 (5.7%); e) had a do-not-resuscitate order written within 96 hrs, 11 (1.0%); f) were previous participants, 7 (0.7%); g) were postoperative patients, 3 (0.3%); h) had a nosocomial MICU BSI within 96 hrs of MICU admission, 3 (0.3%); and i) were missed by study staff (unknown eligibility), 18 (1.7%).
The 138 patients spent a total of 1,420 study days in the MICU. No nutritional supplementation was provided during 335 days (23.6%). Patients received enteral nutrition alone during 793 days (55.8%) and both enteral and parenteral supplementation during 58 days (4.1%). Parenteral nutrition was exclusively provided during 236 of the 1,420 days (16.6%). During the days when enteral feeding was used (851 days), Jevity was the most commonly used formula (32.4%), followed by Nepro (29.5%), Nutren 2.0 (17.0%), Pro-Peptide (5.8%), and Promote (5.1%). During the remaining enteral feeding days, eight other enteral formulas were used. During 63 of the 851 days (7.4%), two enteral feeding formulas were used.
Respiratory failure was the most common reason for MICU admission, and nearly all participants (92.0%) required mechanical ventilation ( Table 1 ). The mean admission SAPS II score was 52.5 Ϯ 15.4 (predicted MICU mortality of ‫)%05ف‬ (25) . The mean (ϮSD) caloric intake was 49.3 Ϯ 29.2% of ACCP recommendations. Baseline patient characteristics (age, SAPS II score, gender, source of admission, baseline serum albumin and BMI, number of hospital days before MICU admission, and being on mechanical ventilation) were similar across categories of caloric intake. Although the percentages of patients with diabetes, chronic renal insufficiency, and acquired immunodeficiency syndrome did not vary by caloric intake, patients with cirrhosis were less likely to receive higher calories (p Ͻ .01). The percentages of patients with severe chronic obstructive pulmonary disease were different among the categories of caloric intake, but there was no specific trend of the differences.
Patients in the lower caloric intake categories had longer periods without nutritional support following MICU admission (p Ͻ .001, Table 2 ). There were also significant differences in the routes of delivery of nutritional supplementation. Eighty-eight subjects (63.8%) received enteral nutrition exclusively, and 18 patients (13%) received only parenteral nutrition. Although the total number of parenteral nutrition days did not vary across caloric intake category, the proportion of calories provided by the parenteral route was significantly higher for patients in the lower caloric intake categories (p ϭ .04). The proportion of MICU study days during which parenteral nutrition was provided also tended to 
Thirty-one patients (22.5%) had a nosocomial ICU BSI (Table 3) . Nineteen BSIs (61.3%) were primary and 12 (38.7%) were secondary BSIs. The three most common causative organisms for primary BSIs were coagulase negative Staphylococcus, Enterococcus (sp.), and Candida (sp.). For secondary BSIs, pulmonary infections were the most common source, with the urinary tract being the next most frequent source of infection. The most common pathogens for secondary BSIs were Candida (sp.), Enterococcus (sp.), and Staphylococcus aureus.
The risk of BSI was higher for patients receiving Ͻ25% of ACCP-recommended calories, compared with all other patients (p Ͻ .05, Fig. 1 ). Comparisons between each of the other quartiles revealed no important differences, so these three quartiles were subsequently grouped into one caloric intake category (Ն25% of ACCP-recommended calories, Fig. 2b ). Risks of BSI in patients receiving Ͻ25% of ACCP-recommended calories compared with patients who received Ն25% for lag periods of 1-4 days are presented in Figure 2 . There was no apparent association with a 1-day lag between caloric intake and BSI. As the lag period was increased from 2 to 4 days, the association with risk of BSI increased in strength.
Bivariate Cox proportional hazards methods demonstrated that caloric intake and SAPS II score at MICU admission were significant predictors of incident nosocomial BSI (Table 4) . Presence of cirrhosis, severe chronic obstructive pulmonary disease, serum albumin, BMI at MICU admission, average and maximum daily serum glucose concentrations, number of inpatient days before MICU admission, and number of MICU days before initiating nutritional support were not associated with risk of BSI. The proportion and total number of MICU days that patients received parenteral nutrition as well as the percent of total calories provided by the parenteral route were not associated with risk of BSI. In the multivariable analysis, patients who received Ն25% of the ACCP recommended caloric intake had a 73% hazard reduction (95% confidence interval, 32-89%) for nosocomial BSI vs. patients who received Ͻ25%, after adjustment for SAPS II scores. The association between higher caloric intake and decreased hazard of BSI persisted when the analysis was stratified for patients who received enteral nutrition alone vs. any parenteral nutrition (0.35, 95% confidence interval, 0.09 -1.46; and 0.19, 95% confidence interval, 0.06 -0.63, respectively).
DISCUSSION
Results of this study suggest that failing to provide modest levels of nutritional support (caloric intake Ͻ25% of ACCP recommendations) may significantly increase BSI risk in patients who do not take food by mouth for Ն96 hrs after MICU admission.
Changes in nutritional markers commonly have been used to demonstrate the benefits of nutritional support. Unfortunately, improvements in serum protein concentrations, nitrogen balance, and weight gain have not consistently been accompanied by clinical benefits (30 -33) . In addition, traditional measures of nutritional status (serum markers, anthropometric measurements) are not recommended for use with critically ill patients (11), since organ dysfunction and fluid shifts in ICU patients limit the validity of such measurements. Hence, the ACCP guidelines propose providing caloric intake based on a patient's ideal body weight, allowing for adjustment for systemic inflammatory response syndrome. However, no studies to date have confirmed the optimum level of nutritional support in the ICU. The categorization of caloric intake for the current study was data driven, as we attempted to balance the categories with comparable numbers of patients in each quartile. Caloric intake of Ն25% of ACCP recommendations (approximately 6 kcal·kg Ϫ1 ·day Ϫ1 ) was strongly associated with reduced risk of BSI, and this association could not be explained by comorbidities, reason for MICU admission, average daily serum glucose, average daily maximum glucose, baseline nutritional status, severity of illness on MICU admission, time to initiating nutrition, and route of nutrition.
Cumulative risk of an ICU nosocomial BSI is dependent on the number of days spent in the MICU (e.g., cumulative risk for a patient in the MICU for 5 days may be lower than for patients in the MICU 20 days). Because we were particularly interested in comparing the risk of BSI, independent of differences in MICU lengths of stay, survival analysis was employed. In addition, we assumed there is a lag period between administration of calories and its effect on the risk of developing a nosocomial BSI. We chose a lag time of 2 days before the risk of BSI to account for the likelihood that benefits of recently provided nutrition would require sufficient passage of time to influence the risk for developing a BSI. To validate our assumption, we performed a sensitivity analysis using lag periods from 1 to 4 days. This analysis suggested that current caloric intake may influence risk of BSI at two or more days in the future. The lack of an immediate effect (i.e., Ͻ2-day lag) was evidence in favor of this assumption, as we did not anticipate a benefit of calories in the period immediately after administration.
Currently, the mechanism by which providing small amounts of calories to critically ill patients could protect from development of nosocomial BSIs remains speculative. Small volumes of enteral nutrition, by protecting against translocation of bacteria across the gut lining, may be partly responsible for some of the protection against infection (34) . This mechanism would not explain why participants receiving parenteral nutrition also appear to benefit. Also perplexing is the absence of additional benefit with increasing caloric intake. A recent clinical trial has a Primary BSIs were bacteremias or fungemias that occurred in patients without any other apparent source of the infection (except for the presence of a central venous catheter); b may have more than one pathogen isolated per BSI, so sum of percents are Ͼ100%. Secondary BSIs had the same organism isolated from the blood and a clinically identified secondary site (Ref. 26) . demonstrated insulin administration to maintain serum glucose between 80 and 110 mg/dL reduces the risk of BSI in critically ill patients (35) . We, therefore, assessed whether the level of glycemia confounded the association between lower caloric intake and BSI. Our study, which was completed before publication of the benefit of aggressive insulin administration, had higher glucose concentrations (mean daily glucose, 167 Ϯ 61 mg/dL and mean daily maximum glucose, 187.8 Ϯ 69.8 mg/dL, mean Ϯ SD) than the target concentration of the recent clinical trial; however, glycemic levels were not associated with caloric intake or risk of BSI. Although many of our study patients may have had lower risks of BSI if aggressive insulin administration was used, the demonstrated association between caloric intake and BSI appears to be independent of glucose concentration.
Most studies have focused on the timing of nutritional support (early vs. late) (18, 32, (37) (38) (39) and the various routes of administration (enteral vs. parenteral) (40 -42) . Attempts to deliver 100% of nutritional goals via enteral feeding very early in the ICU stay recently have been associated with an increased incidence of ventilator-associated pneumonia and Clostridium difficile diarrhea in medical ICU patients (38) . In our study, which did not assess ventilator-associated pneumonia, the number of days before initiating nutritional support was associated with level of caloric intake but was not associated with risk of BSI. Perhaps no relationship to BSI was noted since most of the patients were fed relatively early (1.8 Ϯ 1.2 days, mean Ϯ SD) or because many ventilator-associated pneumonias and Clostridium infections do not result in bacteremia. Furthermore, in our study, despite using a variety of means to account for parenteral nutrition, we also did not find a significant relationship between parenteral nutrition and development of BSI. Support for use of enteral feeding over parenteral feeding is largely based on cost, prevention of bacterial translocation from the gut, and reduced infectious complications (41, 43) . Excluding cost issues, recent reviews have questioned the benefit of enteral nutrition on infections in nonsurgical patients (43) (44) . Furthermore, a recently completed prospective trial that included critically ill patients demonstrated no difference in rates of infection between patients receiving enteral or parenteral nutrition (42) . These ob- Figure 2 . Kaplan-Meier curves comparing calories provided (Ͻ25% vs. Ն25% American College of Chest Physicians-recommended calories) using different lag periods. Each Kaplan-Meier plot represents the time to first medical intensive care unit (MICU) nosocomial bloodstream infection (BSI) for patients in a specific nutrition category. The lagging period refers to the number of days prior to the BSI of patient censoring that the calories received were not considered to influence the risk of BSI. For instance, if a patient developed a BSI on MICU day 6, and the lagging period was 3 days, only the calories received for the first three MICU days would be used in the analysis. The p values were determined by log-rank testing.
servations suggest the need for further research to understand how optimal timing and route of feeding affect outcomes of critically ill patients. This study's results encourage providing nutritional support to patients in the MICU and show that practice consistent with the ACCP guidelines may protect from nosocomial BSI. Nosocomial BSI was chosen to be the primary outcome because a) BSIs impart enormous morbidity and mortality to critically ill patients; b) the diagnosis of BSI was based on objective criteria and therefore is unlikely to be affected by investigator bias (unlike other nosocomial infections such as ventilator-associated pneumonia); and c) identification was performed through an independent reporting source (Hospital Epidemiology and Infection Control system) that employed validated practices consistent with national standards. Although differences in caloric intake would be expected to be explained by patient factors, the variation of caloric intake was unexplained by severity of illness (Table 1) , which is consistent with previous studies (45) (46) .
The MICU at Johns Hopkins Hospital was staffed by a large number of attending physicians with training in critical care medicine during the study period (n ϭ 22). We speculate that physician practice variation may have explained some of the differences in caloric intake across study participants. Support for the influence of physician behaviors on caloric delivery was provided by a study which demonstrated that irrespective of patient factors, there was an opportunity for clinicians to increase caloric intake in ICU practice (47) . Moreover, several previous investigators have found that physician nutritional support practices vary and contribute to underfeeding among ICU patients (46, 48 -49) . Whether provision of low caloric intake increases the risk of BSI or is a marker for other physician practices that confer an increased risk of BSI (nonadherence to infection control guidelines, improper use of antibiotics) is unknown. The current study does not allow us to evaluate this potential confounding.
Despite our rigorous approach, this study, as with all other observational studies, cannot exclude the possibility of confounding by indication. We adjusted the association of caloric intake and BSI for a number of potential confounders (e.g., severity of illness, route of feeding, serum glucose), but there are other potential confounders we did not measure (e.g., intravascular or urinary catheters, antibiotics). We suspect, however, that use of devices (e.g., intravascular catheters) and broad-spectrum antibiotics was common, if not universal, given the severity of illness among study participants (92% mechanically ventilated, ‫%05ف‬ predicted hospital mortality rate), thereby reducing the risk that such factors accounted for the relationship between caloric intake and development of BSI. Nevertheless, we cannot exclude the possibility of these or other unmeasured confounders. In addition, different nutritional formulas provide varying amounts of nutrients including vitamins and minerals. Therefore, it is possible that differences in one of these of components of formulas, rather than caloric intake per se, may protect from the development of nosocomial BSI.
CONCLUSIONS
Caloric intake of Ͻ25% of ACCP recommendations (Ͻ6 kcal·kg Ϫ1 ·day Ϫ1 ) was associated with increased risk of nosocomial BSI among medical ICU patients. Whether different thresholds of caloric intake exist for other clinically important outcomes (e.g., liberation from mechanical ventilation, ICU survival) needs further study. a Only significant bivariate predictors of BSI risk were included in the multivariable model; b SAPS II measured at MICU admission (theoretical range is 0 -182, with higher scores correlated with increasing severity of illness).
